{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:58:17Z","timestamp":1760821097196,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.transproceed.2019.02.061","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T17:16:52Z","timestamp":1567099012000},"page":"2611-2614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness of Thymoglobulin Induction Therapy in Kidney Transplant From Deceased Donor With Mild to Moderate Acute Kidney Injury"],"prefix":"10.1016","volume":"51","author":[{"given":"Chang Hun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Gyo","family":"Gwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Woong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.02.061_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11315940-000000000-00000","article-title":"Rabbit antithymocyte globulin (Thymoglobulin\u00ae)","volume":"70","author":"Gaber","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2019.02.061_bib2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1592\/phco.26.12.1771","article-title":"Rabbit antithymocyte globulin induction therapy in adult renal transplantation","volume":"26","author":"Hardinger","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.transproceed.2019.02.061_bib3","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transproceed.2019.02.061_bib4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/ndt\/gfn009","article-title":"A\u00a0comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients","volume":"23","author":"Bagshaw","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2019.02.061_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell\u2013mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.02.061_bib6","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","article-title":"Delayed graft function in the kidney transplant","volume":"11","author":"Siedlecki","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.02.061_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1600-6143.2009.02651.x","article-title":"Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance","volume":"9","author":"Akkina","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.02.061_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1681\/ASN.2009040412","article-title":"Delayed graft function and the risk for death with a functioning graft","volume":"21","author":"Tapiawala","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.02.061_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/01.tp.0000280553.23898.ef","article-title":"Trends in kidney transplantation in Australia and New Zealand","volume":"84","author":"Chang","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.02.061_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-6143.2008.02505.x","article-title":"Outcomes and utilization of kidneys from deceased donors with acute kidney injury","volume":"9","author":"Kayler","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.02.061_bib11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/ajt.13144","article-title":"Associations of deceased donor kidney injury with kidney discard and function after transplantation","volume":"15","author":"Hall","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.02.061_bib12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/SLA.0000000000000496","article-title":"Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation","volume":"259","author":"Pilch","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.transproceed.2019.02.061_bib13","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.transproceed.2010.02.088","article-title":"Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis","volume":"42","author":"Liu","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.02.061_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2362.2011.02490.x","article-title":"Long-term outcome of ATG vs. basiliximab induction","volume":"41","author":"Ulrich","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.transproceed.2019.02.061_bib15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/01.TP.0000134399.10352.E4","article-title":"The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function","volume":"78","author":"Knight","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.02.061_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.tp.0000268084.64888.f3","article-title":"Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety","volume":"84","author":"Kyll\u00f6nen","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.02.061_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/tri.12043","article-title":"Selection of induction therapy in kidney transplantation","volume":"26","author":"Hardinger","year":"2013","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2019.02.061_bib18","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/ajt.13260","article-title":"Transplanting kidneys from deceased donors with severe acute kidney injury","volume":"15","author":"Heilman","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.02.061_bib19","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(04)17406-0","article-title":"Delayed graft function in kidney transplantation","volume":"364","author":"Perico","year":"2004","journal-title":"Lancet"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518318578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518318578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:32:35Z","timestamp":1758576755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518318578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0041134518318578"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.02.061","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Thymoglobulin Induction Therapy in Kidney Transplant From Deceased Donor With Mild to Moderate Acute Kidney Injury","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.02.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}